Orgenesis Inc. Common Stock
ORGS
ORGS was delisted on the 18th of October, 2024.
16 hedge funds and large institutions have $1.3M invested in Orgenesis Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 6 closing their positions.
65% more capital invested
Capital invested by funds: $784K → $1.3M (+$513K)
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
0.29% less ownership
Funds ownership: 4.91% → 4.62% (-0.29%)
16% less funds holding
Funds holding: 19 → 16 (-3)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$26K |
| 2 |
RFN
Redwood Financial Network
Solon,
Ohio
|
+$13.4K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$828 |
| 4 |
CAL
Capital Advisors Ltd
Shaker Heights,
Ohio
|
+$454 |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$160 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$11.2K |
| 2 |
Jane Street
New York
|
-$6.01K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$5.89K |
| 4 |
Prudential Financial
Newark,
New Jersey
|
-$5.51K |
| 5 |
Renaissance Technologies
New York
|
-$2.24K |
ORGS Hedge Fund Activity: Q1 2024 in Review
16 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Orgenesis Inc. Common Stock (ORGS) for Q1 2024, worth a combined $1.3M — up 65% from $784K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of ORGS and 3 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 5 added.
The largest buyer was Geode Capital Management, adding an estimated $26K. The largest seller was State Street, cutting an estimated $11.2K.
- 16 institutional investors held Orgenesis Inc. Common Stock (ORGS) as of Q1 2024, down from 19 in Q4 2023.
- Funds reported $1.3M of Orgenesis Inc. Common Stock stock for Q1 2024, up 65% quarter-over-quarter.
- 3 funds opened new Orgenesis Inc. Common Stock positions in Q1 2024 and 6 closed out, a net change of -3 holders.
- The largest Orgenesis Inc. Common Stock buyer in Q1 2024 was Geode Capital Management, an estimated $26K added.
- The largest Orgenesis Inc. Common Stock seller in Q1 2024 was State Street, an estimated $11.2K sold.
Based on aggregated 13F filings for Q1 2024.